A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the safety of OPC-262 administered orally in combination with another oral antihyperglycemic agent

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01193179
Study type	Interventional
Source	Kyowa Hakko Kirin Company, Limited
Contact
Status	Completed
Phase	Phase 3
Start date	July 2010
Completion date	April 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01805414` - Breakfast Nutrition and Inpatient Glycemia	N/A
Completed	`NCT01427660` - iDecide.Decido: Diabetes Medication Decision Support Study	N/A
Completed	`NCT02648685` - The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM
Completed	`NCT00141232` - Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT03397225` - A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control	N/A
Completed	`NCT01837680` - Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy	N/A
Completed	`NCT01336738` - Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus	Phase 2
Completed	`NCT00308737` - Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes	Phase 3
Completed	`NCT00246987` - A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control	Phase 3
Completed	`NCT00857558` - A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes	Phase 2
Terminated	`NCT01350102` - The Relationship of Hemoglobin A1c and Diabetic Wound Healing	Phase 4
Completed	`NCT01624116` - Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes	N/A
Completed	`NCT01634282` - Along-term Study of OPC-262 in Patients With Type 2 Diabetes	Phase 3
Withdrawn	`NCT02222623` - The Inova Type 2 Diabetes Mellitus Study	N/A
Recruiting	`NCT06340854` - A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes	Phase 3